6593 POSTER Nerve growth factor (NGF) levels in plasma in patients with advanced non-small cell lung cancer patients (NSCLC). Is it predictive of clinical outcome?

R.Sirera; C.Camps; C.Caballero; M.J.Safont; A.Blasco; J.Gavila; A.Cabrera-Pastor; V.Iranzo; M.Taron; R.Rosell

首页> 外文期刊>European Journal of Cancer Supplements >6593 POSTER Nerve growth factor (NGF) levels in plasma in patients with advanced non-small cell lung cancer patients (NSCLC). Is it predictive of clinical outcome?

【24h】

6593 POSTER Nerve growth factor (NGF) levels in plasma in patients with advanced non-small cell lung cancer patients (NSCLC). Is it predictive of clinical outcome?

机译：6593 POSTER晚期非小细胞肺癌患者（NSCLC）患者血浆中神经生长因子（NGF）的水平。它可以预测临床结果吗？

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2007年第4期|共1页
作者
R.Sirera; C.Camps; C.Caballero; M.J.Safont; A.Blasco; J.Gavila; A.Cabrera-Pastor; V.Iranzo; M.Taron; R.Rosell;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 6611 POSTER Determination of the prognostic value blood levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in advanced non-small cell lung cancer (NSCLC) patients [J] . C.Camps, R.Sirera, V.Alberola, European Journal of Cancer Supplements . 2007,第4期

机译：6611 POSTER测定晚期非小细胞肺癌（NSCLC）患者的血管内皮生长因子（VEGF）和碱性成纤维细胞生长因子（bFGF）的预后价值
2. 6591 POSTER Analysis of the progostic value of the quantification of plasmatic epidermal growth factor receptor (EGFR) in advanced non-small cell lung cancer (NSCLC) patients [J] . R.Sirera, C.Camps, G.Lopez-Vivanco, European Journal of Cancer Supplements . 2007,第4期

机译：6591 POSTER对晚期非小细胞肺癌（NSCLC）患者血浆表皮生长因子受体（EGFR）定量的预后价值分析
3. 6569 POSTER The quantification of plasmatic free DNA is a prognostic factor in advanced non-small cell lung cancer (NSCLC) patients [J] . C.Camps, R.Sirera, R.M.Bremnes, European Journal of Cancer Supplements . 2007,第4期

机译：6569海报血浆游离DNA的定量是晚期非小细胞肺癌（NSCLC）患者的预后因素
4. Enumeration and ALK Investigation of Circulating Tumor Cells in Non-Small Cell Lung Cancer (NSCLC) Patients Using an Effective In Vivo Technology, the GILUPI CellCollector? [C] . Klaus Luecke, Lukasz Gasiorowski, Stefanie Herold, International Molecular Medicine Tri-Conference. . 2015

机译：使用有效的体内技术（Gilupi Cellcollector
5. Symptoms Leading to Nutritional Risk in Advanced Non-Small Cell Lung Cancer Patients: The Importance of Nutritional Screening in the Advanced Lung Cancer Population [D] . Swinton, Nelda. 2009

机译：导致晚期非小细胞肺癌患者营养风险的症状：在晚期肺癌人群中进行营养筛查的重要性
6. Selective gene amplification to detect the T790M mutation in plasma from patients with advanced non-small cell lung cancer (NSCLC) who have developed epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) resistance [O] . Shingo Nishikawa, Hideharu Kimura, Hayato Koba, 2018

机译：选择性基因扩增可检测患有表皮生长因子受体酪氨酸激酶抑制剂（EGFR-TKI）耐药的晚期非小细胞肺癌（NSCLC）患者血浆中的T790M突变
7. P2-097: Determination of nerve growth factor (NGF) levels in plasma in patients with advanced non-small cell lung cancer patients (NSCLC). Its correlation with clinical outcome [O] . Camps Carlos, Sirera Rafael, Blasco Ana, 2007

机译：P2-097：晚期非小细胞肺癌（NSCLC）患者血浆中神经生长因子（NGF）水平的测定。与临床结果的关系

6593 POSTER Nerve growth factor (NGF) levels in plasma in patients with advanced non-small cell lung cancer patients (NSCLC). Is it predictive of clinical outcome?

著录项

相似文献

相关主题

期刊订阅